Navigation Links
Antares Pharma Announces Positive Results from Application Site,Study for Anturol

s, Minnesota and Basel, Switzerland.

Safe Harbor Statement

In addition to historical facts or statements or current conditions, this press release contains forward-looking statements within the meaning of the "Safe Harbor" provisions of The Private Securities Litigation Reform Act of 1995, including statements regarding the positive results. Forward-looking statements provide Antares' current expectation or forecasts of future events. Antares' results could differ materially from those reflected in these forward-looking statements due to decisions of regulatory authorities, Antares' ability to execute on its development plans and general financial, economic, regulatory and political conditions affecting the pharmaceutical industry generally. For a discussion of these and other risks and uncertainties that may effect the forward-looking statements, please see the risk factors in Antares' 10Q's, 10K's and other filings made with the Securities and Exchange Commission. Given these risks and uncertainties, any or all of these forward-looking statements may prove to be incorrect. Antares undertakes no obligation to update publicly any forward-looking statement.

Contact

Antares Pharma, Inc.
Stephanie M. Baldwin, 609-359-3020
sbaldwin@antarespharma.com


'"/>




Page: 1 2 3

Related medicine technology :

1. Sygnis Pharma AG announces date for presentation of clinical results
2. BioSante Pharmaceuticals Announces New Findings for Potential Bird Flu Vaccine
3. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
4. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
5. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
6. Auxilium Pharmaceuticals to Present at the 2007 CEUT Emerging Growth Opportunities Conference
7. Sunesis Pharmaceuticals to Present at the C. E. Unterberg, Towbin Emerging Growth Conference
8. EPIX Pharmaceuticals to Present at the C.E. Unterberg, Towbin Emerging Growth Opportunities Conference
9. Array BioPharma to Present at the C.E Unterbeg, Towbin Emerging Growth Conference
10. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
11. TransPharma Medical Announces Positive Results of Phase I Clinical Trials for Transdermal Delivery of hPTH (1-34) for Osteoporosis Treatment
Post Your Comments:
(Date:6/3/2015)... 2015  Giving people with low vision hope – ... International Academy of Low Vision Specialists (IALVS), ... at the forefront of low vision care. The academy ... and latest treatment options available to patients who present ... traditional means. Recently, doctors in six new states and ...
(Date:6/3/2015)... Va. , June 3, 2015  PARI Respiratory Equipment ... Pak ® .  Kitabis Pak, approved by the FDA on ... solution with a PARI LC PLUS ® Nebulizer for ... all the hard work we put into this unique product ... that is easy for patients to use, we also wanted ...
(Date:6/3/2015)...  OncoSec Medical Inc. ("OncoSec") (NASDAQ: ONCS ... today announced that it has entered into definitive ... approximately $13.6 million of securities in a registered ... such investors an aggregate of 2,469,091 shares of ... per share. The gross proceeds ...
Breaking Medicine Technology:International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 2International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 3International Academy of Low Vision Specialists Announces Training of Doctors in Six New States and Canada 4Kitabis Pak Wins American Package Design Award 2OncoSec Medical Announces $13.6 Million Registered Direct Offering 2OncoSec Medical Announces $13.6 Million Registered Direct Offering 3
(Date:6/3/2015)... The National Resident Matching Program ... Savoia, M.D., Dean of Medical Education at the University of ... on July 1. , “It is an honor ... Matching Program,” said Dr. Savoia. “NRMP’s goal is to ... students with training programs, and I welcome the opportunity to ...
(Date:6/3/2015)... California (PRWEB) June 03, 2015 ... biopharmaceuticals or biologics has revolutionized disease treatment on account ... cancer and autoimmune diseases, such as rheumatoid arthritis. The ... the use of traditional small molecule drugs to biopharmaceuticals ... monoclonal antibodies (mAbs), cell and gene therapies, and recombinant ...
(Date:6/3/2015)... On June 22, 2015, Medicare will begin ... (pharmacogenetic) testing that it has reimbursed since 2009. , ... million of the 49 million Medicare beneficiaries in the U.S. ... drug events.(1) Sadly, if it became a standard of care, ... use of an individual’s genetic information to tailor treatment, is ...
(Date:6/3/2015)... On the heels of a report predicting ... 2020 ( click here to review news coverage about ... Baltimore has the talent to become a world-leading center ... and other biological data are collected and analyzed to help ... all the elements of a perfect storm for bioinformatics leadership,” ...
(Date:6/3/2015)... 2015 Vancouver personal injury lawyers at ... will now handle personal injury claims resulting due to ... rise, more and more people turn towards mass transportation ... needless suffering, serious injury and also deaths. , ... bus accident in BC you may have an ICBC ...
Breaking Medicine News(10 mins):Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 2Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 3Health News:NRMP Board of Directors Elects New Leadership and Members at its May 2015 Meeting 4Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 2Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 3Health News:Superior Efficacy of Biopharmaceuticals Against Chronic Diseases Drives the Global Biopharmaceuticals Market, According to a New Report by Global Industry Analysts, Inc. 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 2Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 3Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 4Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 5Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 6Health News:Medicare Limiting Coverage Benefit for Drug Sensitivity Testing on June 22, 2015 7Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 2Health News:Baltimore Poised to Become a World-Leading Hub of Multi-Billion Dollar Bioinformatics Industry 3Health News:Jiwa Law Corporation Now Handles Personal Injury Claims Involving Bus Accidents 2
... ... own the issue of “medication adherence.” , ... Alexandria, VA (Vocus) April 10, 2010 -- An article in ... fueling the National Association of Chain Drug Stores’ (NACDS) message that pharmacy’s role in ...
... Key Topics in Surgical Research and Methodology represents a ... an academic career. Four key elements are covered: ... Research as well as Recent Developments and Future Prospects ... "The aim of this book is to equip surgeons ...
... the United States has experienced a conflict with a ... care, researchers from the University of Chicago report in ... of General Internal Medicine . Younger and less ... than their older or more religious peers. Most primary ...
... say , FRIDAY, April 9 (HealthDay News) -- Doctors ... detect chronic liver disease in children, new research finds. ... (ALT) activity, is designed to detect liver disease or ... assessment of the test levels considered to be signs ...
... begin exercise program early recover faster, reduce sedative use, research ... patients in the intensive care unit may reduce their use ... exercise, a new study has found. , The amount of ... patients to exercise, which reduced the amount of muscle weakness ...
... ... was named a 2009 “Purveyor of the Year” by Outback Steakhouse Inc. (OSI) for ... custom, strategic learning solutions to help cascade strategies throughout its workforce to increase satisfaction ... ...
Cached Medicine News:Health News:New England Journal of Medicine Article Trumpets “Priority” Status of Helping Patients Take Medications Correctly 2Health News:New England Journal of Medicine Article Trumpets “Priority” Status of Helping Patients Take Medications Correctly 3Health News:Primary care physicians nationwide face clinical ethical conflicts with religious hospitals 2Health News:Liver Disease May Go Undetected in Children 2Health News:Mild Exercise Good for the Critically Ill 2Health News:Root Learning Named “Purveyor of the Year” For Strategic Partnership with Outback Steakhouse 2
... 20-year history, the VOYAGER RX Dilatation Catheter ... outcomes. It combines a new low profile, ... shaft,more flexible markers, and short taper balloon ... tortuous anatomy with even greater confidence, opening ...
... Utilizing technology developed over Guidants 20-year history, ... new foundation for successful treatment outcomes. It ... design with a lower profile shaft,more flexible ... you can cross tight and tortuous anatomy ...
... Utilizing technology developed over Guidants 20-year ... the new foundation for successful treatment outcomes. ... tip design with a lower profile shaft,more ... Now you can cross tight and tortuous ...
The assay is an immunometric ('sandwich') EIA for the quantitative measurement of AFP in human serum or plasma....
Medicine Products: